logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

木头姐2026布局转向,重仓基因编辑技术

Cathie Wood’s ARK Invest Shifts 2026 Strategy, Heavily Bets on Gene Editing Technology

Jan 5, 2026

Life Science

诺和诺德首发口服减肥药,百亿美元市场格局生变

Novo Nordisk Launches Oral Weight-Loss Drug, Shifting the $100 Billion Market Landscape

Jan 5, 2026

Life Science

Double Victory for Eli Lilly: Superior Weight-Loss Data & Bold Vaccine Expansion

Nektar Therapeutics Too Risky? This Biotech Stock Offers a Safer Bet

Jan 5, 2026

Life Science

Defense Tech Heat Check: PSN, LDOS, BAH, CACI, SAIC

Jan 5, 2026

Life Science

Is Pfizer’s 6.5% Dividend a Yield Trap? Q1 Results Put Speculation to Rest

Is Pfizer Stock, Now Under $25, a Buy?

Jan 1, 2026

Life Science

为什么这两只成长股能在2031年前持续跑赢大盘?

Why Can These Two Growth Stocks Continue to Outperform the Market Until 2031?

Dec 31, 2025

Life Science, Technology

股价上涨1323%之后,英伟达的下一个驱动力?

Eli Lilly Plans to Acquire Abivix, Could This Deal Become a New Growth Engine?

Dec 31, 2025

Life Science

百时美施贵宝押注未来,哪些管线将成为新增长支柱?

Bristol-Myers Squibb Bets on the Future, Which Pipelines Will Become the New Pillars of Growth? 

Dec 30, 2025

Life Science

英伟达之后,博通将成为下一个2万亿美元芯片巨头

Towards 2026, Focusing on Three High-Potential Biotechnology Companies

Dec 29, 2025

Life Science

CRISPR Therapeutics Soars as Partner Vertex Drops Optimistic 2026 Sales Guidance

Can These Two Battered Biotech Stocks Stage a Comeback in 2026?

Dec 29, 2025

Life Science

Who Will Lead in 2026? Analysts Identify the Next Cohort of U.S. Growth Stocks

Who Will Lead in 2026? Analysts Identify the Next Cohort of U.S. Growth Stocks

Dec 28, 2025

Financial Service, Life Science, Technology

Bold Forecast: Executive Order Paves Way for Federal Cannabis Legalization by 2026

Bold Forecast: Executive Order Paves Way for Federal Cannabis Legalization by 2026

Dec 28, 2025

Cannabis

药物获批与收购潜力形成“双击”,Travere Therapeutics股价获强劲助推

Drug Approval and Acquisition Potential Form a “Double Boost,” Providing Strong Momentum for Travere Therapeutics’ Stock Price

Dec 24, 2025

Life Science

Apple Stock Is Down 9% This Year. History Says It’s a Buying Opportunity

Looking for a “Forever” Stock? These 2 Healthcare Picks Are Worth Considering

Dec 24, 2025

Life Science

逆市大涨!生物技术公司格劳科斯股价飙升近14%

The Logic Behind Institutions’ Heavily Weighted and Counter-Cyclical Increase in Holdings of Lantheus 

Dec 24, 2025

Life Science

UnitedHealth Soars 36.9% in April, As Earnings Beat Unlocks Valuation Recovery Runway

Oral Obesity Pill Arrives: Has Novo Nordisk Stock Finally Hit Bottom?

Dec 23, 2025

Life Science

Why Eli Lilly Is Underrated in the Red-Hot GLP-1 Weight-Loss Drug Race, per Morgan Stanley

Looking Beyond Novo Nordisk, High-Yield Pfizer Is a Bigger Contrarian Opportunity

Dec 22, 2025

Life Science

医疗保健股冰火两重天:一支潜力股与两支需观察的股票

Who Will Lead the Future? Predictions for Healthcare Companies with the Greatest Growth Potential in 2026 

Dec 19, 2025

Life Science

  • ‹‹ Previous
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada